KB
Kylix Bio, Inc.
SEC filingBiotechnology · Dover, DE
Amount raised$850Ksold at filing
Total offering$12M$11.2M still open
Investors in the raise5count reported to the SEC
FiledJan 26, 2026first sale Jan 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Madeleine F. ClarfieldDirector
Hunter P.W. WattsDirector
Catherine P.W. IllingworthExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.